Three types of amyloid protein precursor mRNA in human brain: Their differential expression in Alzheimer's disease

https://doi.org/10.1016/S0006-291X(88)80273-0Get rights and content

Summary

Three types of amyloid protein precursor (APP) mRNA, produced by alternative splicing, were detected by Northern blotting in human brains, both control and Alzheimer's disease. These mRNAs encode APP695 consisting of 695 amino acids, APP751 harboring a 56 amino acid insert homologous to a Kunitz-type trypsin inhibitor inside APP695, and APP770 containing an additional 19 amino acid insert. Another possible APP mRNA which encodes “APP714” containing a 19 amino acid insert was not found in brain samples tested. Quantitative analysis revealed that, although the relative expression levels of the three mRNAs were variable among individuals, there was no remarkable change in expression of APP695 and APP751 mRNAs in Alzheimer's disease compared with control, but that APP770 mRNA level was elevated significantly in Alzheimer's disease.

References (26)

  • MountjoyC.Q. et al.

    J. Neurol. Sci.

    (1982)
  • GlennerG.G. et al.

    Biochem. Biophys. Res. Commun.

    (1984)
  • FuruyaH. et al.

    Biochem. Biophys. Res. Commun.

    (1988)
  • MastersC.L. et al.
  • WongC.W. et al.
  • MastersC.L. et al.

    EMBO J.

    (1985)
  • KangJ. et al.

    Nature (London)

    (1987)
  • RobakisN.K. et al.
  • GoldgaberD. et al.

    Science

    (1987)
  • TanziR.E. et al.

    Science

    (1987)
  • SchubertD. et al.

    Science

    (1988)
  • KitaguchiN. et al.

    Nature (London)

    (1988)
  • PonteP. et al.

    Nature (London)

    (1988)
  • Cited by (128)

    • Alternative splicing regulation of APP exon 7 by RBFox proteins

      2014, Neurochemistry International
      Citation Excerpt :

      Base substitutions of the GCAUG sequence in APP6789 minigenes reduced the effect of RBFox1. Alternations of APP isoform expression in AD brains have been reported (Tanaka et al., 1988; Johnson et al., 1990; Moir et al., 1998; Li et al., 1999; Preece et al., 2004; Matsui et al., 2007). Therefore, our findings provided a potentially important aspect by which RBFox proteins might contribute to the production of Aβ via splicing regulation.

    • Expression and function of APP and its metabolites outside the central nervous system

      2013, Experimental Gerontology
      Citation Excerpt :

      Amyloid precursor protein (APP) is a type I integral membrane protein with a large extracellular N-terminal domain, a hydrophobic transmembrane domain, and a short C-terminus intracellular domain (Dyrks et al., 1988; Kang et al., 1987). There are three major isoforms of the protein derived from alternative splicing, APP751, APP770, APP695, with APP695 demonstrating highest levels of expression in brain (Ponte et al., 1988; Tanaka et al., 1988, 1989). APP processing has recently been extensively described elsewhere (Zhang et al., 2012; Zheng and Koo, 2011) and will, therefore, not be heavily detailed here.

    • A Two Decade Contribution of Molecular Cell Biology to the Centennial of Alzheimer's Disease: Are We Progressing Toward Therapy?

      2006, International Review of Cytology
      Citation Excerpt :

      Within the APP ectodomain, two main domains with different putative functions can be discerned, i.e., the E1 region and the carbohydrate region, bridged via an unstructured highly flexible acidic stretch (Fig. 1A) (Reinhard et al., 2005). In the APP751/770 splice variants, the KPI and Ox2 sequences (Tanaka et al., 1988) are situated between this acidic region and the carbohydrate domain. In the E1 region, two domains can be distinguished, the cystein‐rich N‐terminal growth factor‐like domain (GFLD) (aa 23–128) and the copper‐binding domain (CuBD) (aa 124–189) (Fig. 1A).

    View all citing articles on Scopus
    View full text